Increased Neutrophil CD64 and HLA-DR Expression in Severe COVID-19: A Case-Control Flow Cytometry Study
Viral Immunology · 01.12.2026 · 39 (9-10) · 334-340
DOI: 10.1177/08828245261493338 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Viral Immunology, online erschienen am 28.09.2026. Verfasst von Abdulelah Aljuaid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia. Hauptthemen laut MEDLINE: COVID-19, Neutrophils, HLA-DR Antigens, Receptors, IgG. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
COVID-19 presents with various symptoms, including fever, dyspnea, and respiratory failure. Understanding its pathogenesis is crucial, particularly the role of early immune responders such as neutrophils.
Objectives
The study aimed to investigate neutrophil phenotypes and activation in patients with severe COVID-19, focusing on the expression of key activation markers and their potential role in disease severity.
Methods
A case-control study was conducted in Makkah City involving 88 participants. The study group consisted of 48 PCR-confirmed severe COVID-19 patients with elevated C-reactive protein (CRP) levels and proinflammatory cytokine levels, and the control group included 40 healthy individuals. EDTA-anticoagulated whole blood samples were collected from all participants. Neutrophil counts were obtained, and flow cytometry was performed to assess the expression of activation markers CD64 and HLA-DR on neutrophils.
Results
Severe COVID-19 patients exhibited significantly elevated neutrophil counts compared to healthy controls. Flow cytometric analysis revealed significantly increased CD64 and HLA-DR mean fluorescence intensity on neutrophils from patients with severe COVID-19 compared with healthy controls, indicating a heightened state of neutrophil activation.
Conclusion
Severe COVID-19 was associated with increased neutrophil activation, reflected by elevated CD64 and HLA-DR expression. These findings support the potential value of neutrophil immunophenotyping in characterizing innate immune dysregulation during severe COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
- Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
ORCID-Profile: Abdulelah Aljuaid
Zitieren
APA
Aljuaid, A., Allahyani, M., Izmirly, A., Alharbi, A. M., Jambi, K., & Almehmadi, M. (2026). Increased Neutrophil CD64 and HLA-DR Expression in Severe COVID-19: A Case-Control Flow Cytometry Study. Viral Immunology, 39(9-10), 334-340. https://doi.org/10.1177/08828245261493338
Vancouver
Aljuaid A, Allahyani M, Izmirly A, Alharbi AM, Jambi K, Almehmadi M. Increased Neutrophil CD64 and HLA-DR Expression in Severe COVID-19: A Case-Control Flow Cytometry Study. Viral Immunology. 2026;39(9-10):334-340. doi:10.1177/08828245261493338
BibTeX
@article{Aljuaid2026,
author = {Aljuaid, Abdulelah and Allahyani, Mamdouh and Izmirly, Abdullah and Alharbi, Ahmad M and Jambi, Khalid and Almehmadi, Mazen},
title = {Increased Neutrophil CD64 and HLA-DR Expression in Severe COVID-19: A Case-Control Flow Cytometry Study},
journal = {Viral Immunology},
year = {2026},
volume = {39},
number = {9-10},
pages = {334--340},
doi = {10.1177/08828245261493338}
}
EUVIMED